GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Anhui Sunhere Pharmaceutical Excipients Co 300452.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

11.82

0.00%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

About Anhui Sunhere Pharmaceutical Excipients Co

Its shares trade on Shenzhen under the ticker 300452.SZ. It has been listed since 15 May 2015. In the fiscal year to 31 December 2025, it reported revenue of CN¥942.8m and net income of CN¥176.6m. At that date it held total assets of CN¥1.71bn and shareholders' equity of CN¥1.01bn.

Anhui Sunhere Pharmaceutical Excipients Co., Ltd. engages in the research and development, production, and sale of pharmaceutical excipients. The company is headquartered in Huainan, Anhui. The company went IPO on 2015-05-15. is principally engaged in the research and development, production and distribution of pharmaceutical excipients. Its major products include cellulose microciystalline, esium stearate, carboxymethyl starch sodium, hydroxypropyl methyl cellulose, hydroxypropyl cellulose, film coating powder, carboxymethylcellulose sodium, medicinal dextrin, medicinal starch and silicon dioxide, among others. Its products are mainly used in the production of filler, adhesive, disintegrating agent, lubricating agent and coating materials, among others.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
15 May 2015
Employees
905
Website
shanhe01.com ↗

Leadership

Pay as last reported

  • Mr. Daocai SongActing Chairman of the Board, General Manager
  • Mr. Tangdong ZhuFinance Director, Deputy General Manager, since 2024
  • Mr. Zihu LiuDeputy General Manager, since 2021
  • Mr. Lisheng PanDeputy General Manager, since 2024
  • Hao HuSecretary of the Board
  • Ms. Hanfang LeiDirector
  • Ms. Lu LiuDirector
  • Mr. Ping LinIndependent Director
  • Ms. Hong WangIndependent Director
  • Mr. Jianping ZhouIndependent Director, since 2024

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Anhui Sunhere Pharmaceutical Excipients Co Ltd employs 905 full-time employees in Huainan, China.
  • The company produces cellulose microcrystalline and hydroxypropyl methyl cellulose for pharmaceutical use.
  • Anhui Sunhere's products include carboxymethyl starch sodium and medicinal dextrin for drug manufacturing.

Weaknesses

  • The company's products are limited to pharmaceutical excipients without diversification.
  • Anhui Sunhere has no international presence beyond China's domestic market.
  • The company's IPO in 2015 shows no recent expansion or new market entry.

Opportunities

  • The growing pharmaceutical industry in China offers increased demand for excipients.
  • Anhui Sunhere can expand into new product lines within the Health Care sector.
  • The company may benefit from rising healthcare spending in the Chinese market.

Threats

  • Competition from other Chinese pharmaceutical excipient manufacturers remains high.
  • Regulatory changes in China's pharmaceutical sector could impact production.
  • Economic downturns in China might reduce pharmaceutical industry spending.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.